Empagliflozin and Weight Loss: A Promising First-Line Treatment for Diabetes and Prediabetes Table of Contents 1. Empagliflozin and Weight Loss: A Promising First-Line Treatment for Diabetes and Prediabetes 2. Understanding the Study 3. Key Findings 4. What This Means for patients 5. Limitations and Future Directions 6. Conclusion 7. How Does Empagliflozin Contribute to Weight […]
You can read the full story here: Empagliflozin as First-Line Therapy Reduces Weight, BMI, and Waist Circumference in Prediabetes and Diabetes.